Starling Oncology director Brad Hively to step down as vice chairman, not seek re-election in 2027PUBT·Sep 2 at 10:05 AMSTLN-1.96%
Starling Oncology executives join Wells Fargo Healthcare Conference fireside chatPUBT·Aug 24 at 01:02 PMWFC-0.41%
Starling Oncology 10% owner Jorey Chernett acquires 12,000 shares worth $78,480PUBT·Aug 17 at 02:13 PMSTLN-1.96%
Starling Oncology shares are trading higher after the company reported a year-over-year decrease in Q2 loss per share and increase in sales results.benzinga_article·Aug 7 at 05:53 PMSTLN-1.96%
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga_article·Aug 7 at 05:05 PMCVRX+1.54%EMBC-2.87%
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga_article·Aug 7 at 12:05 PMNTRA+0.67%QDEL-2.17%
Starling Oncology lifts FY 2026 revenue outlook to $650-$670 millionPUBT·Aug 6 at 09:50 PMSTLN-1.96%TOI0.00%
Oncology Institute Q2 FY26 net loss narrows 42.4% to $9.79 million; revenue rises 34.6% to $161.28 millionPUBT·Aug 6 at 09:46 PMSTLN-1.96%
Oncology Institute to trade on Nasdaq as STLN from Aug. 4, replacing TOIPUBT·Aug 3 at 12:06 PMTOI0.00%STLN-1.96%
Major Investor Quietly Boosts Position in Oncology PowerhouseTip Ranks·Jul 23 at 02:02 AMTOI0.00%STLN-1.96%
Oncology Institute 10% owner Jorey Chernett buys 18,000 shares valued at $94,860PUBT·Jul 22 at 01:56 PMTOI0.00%STLN-1.96%
Oncology Institute CMO Yale Podnos disposes of 23,452 common shares worth $150,362.95PUBT·Jul 17 at 12:06 AMTOI0.00%STLN-1.96%
